Table 1.
Baseline patient demographics
| Median (interquartile range) or number of patients (%) | |
|---|---|
| Age (years) | 63 (54–71) |
| Male | 122 (51%) |
| Ethnicity | |
| Pacific Islander | 116 (48.5%) |
| European | 66 (28%) |
| Maori | 35 (15%) |
| Asian | 21 (8%) |
| African | 1 (0.5%) |
| Body mass index (m2 kg) | 29 (25–34) |
| Dialysis duration (months) | 38.5 (17.2–70) |
| Coronary artery disease | 79 (33%) |
| Previous coronary revascularisation | 17 (7%) |
| Diabetes mellitus | 154 (64%) |
| Cause of ESRF | |
| Diabetes | 139 (58.2%) |
| Glomerulonephritis | 49 (20.5%) |
| Hypertension | 19 (7.9%) |
| Unknown | 9 (3.8%) |
| Obstructive uropathy | 5 (2%) |
| Adult polycystic kidney disease | 4 (1.7%) |
| Cardiorenal syndrome | 3 (1.3%) |
| Reflux nephropathy | 3 (1.3%) |
| Other | 8 (3.3%) |
| Ejection fraction <50%a | 45 (27% of 160) |
| Ejection fraction <35%a | 17 (10% of 160) |
| Previous smoker | 38 (16%) |
| Current smoker | 26 (11%) |
| Atrial Fibrillation | 26 (11%) |
| Albumin, g/L | 41 (39–43) |
| Calcium, mmol/L | 2.32 (2.21–2.43) |
| Phosphate, mmol/L | 1.65 (1.4–2.1) |
| Parathyroid hormone, pmol/L | 29.5 (13.2–56) |
| Haemoglobin, g/L | 113 (102–122) |
| C-reactive protein, mg/L | 5.8 (2.4–13) |
| HbA1c in diabetics, mg/mmol | 55 (45.5–65.5) |
One patient excluded for incomplete troponin data (n = 238).
aEchocardiogram available in 160 patients.